HeartBeat.bio
HeartBeat.bio is a recently founded drug discovery company focusing on the development of a high-throughput 3D screening platform tackeling cardiomyopathies, cardiotoxicity and heart failure. Our core technology is based on the world-wide first, self-organizing cardiac organoids (cardioids) which resemble the human physiology of a human heart chamber in a way that allows for the cost-efficient […]